PUBLISHER: TechNavio | PRODUCT CODE: 1908912
PUBLISHER: TechNavio | PRODUCT CODE: 1908912
The global pneumococcal vaccine market is forecasted to grow by USD 3273.1 mn during 2025-2030, accelerating at a CAGR of 5.8% during the forecast period. The report on the global pneumococcal vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding immunization programs by government in developing countries, increasing awareness regarding vaccination, growing incidences of pneumococcal diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 5.5% |
| CAGR | 5.8% |
| Incremental Value | $3273.1 mn |
Technavio's global pneumococcal vaccine market is segmented as below:
By Type
By Distribution Channel
By Age Group
Geography
This study identifies the advancements in vaccine technologies as one of the prime reasons driving the global pneumococcal vaccine market growth during the next few years. Also, emergence of novel pneumococcal vaccines and emergence of combination vaccines will lead to sizable demand in the market.
The report on the global pneumococcal vaccine market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pneumococcal vaccine market vendors that include Bharat Biotech Ltd., Biological E. Ltd., CSL Seqirus, GlaxoSmithKline Plc, Inventprise Inc., Johnson and Johnson Services, Merck and Co. Inc., Panacea Biotec Ltd., Petrovax, Pfizer Inc., Sanofi SA, Serum Institute of India Ltd., Shenzhen Kangtai Biological Co, SK Bioscience, Vaxcyte Inc., Walvax Biotechnology Co. Ltd.. Also, the global pneumococcal vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.